Back to Awarded Treatment Trials


Awarded Trial: 03T-350

Grant ID

03T-350

Illness

Schizophrenia

Primary Drug/Intervention

Riluzole

Primary Dosage

100mg

Secondary Drug Intervention

Risperidone

Secondary Dosage

4mg

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Terminated

Investigator

Rujescu

Sample Size

100

Duration of Study Period for Each Subject

4 weeks

Outcome Measurements

PANSS, BPRS, CGI, Extrapyramidal Sympton Rating Scale, Barnes Akathisia Scale

Results

The grant was terminated due to slow enrollment.

Publication

N/A

Link

N/A

PI Name

Dan Rujescu

Degree

MD

Center

Ludwig-Maximillians

Institution

Ludwig-Maximilians Universitaet, Dept. of Psychiatry

Address

Nussbaumstr. 7

City or Town

Munich

State or Province

N/A

Zip or Postal Code

80336

Country

Germany

Email Address

Dan.Rujescu@med.uni-muenchen.de